1. Home
  2. OPTX vs CLSD Comparison

OPTX vs CLSD Comparison

Compare OPTX & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTX
  • CLSD
  • Stock Information
  • Founded
  • OPTX 1981
  • CLSD 2011
  • Country
  • OPTX United States
  • CLSD United States
  • Employees
  • OPTX N/A
  • CLSD N/A
  • Industry
  • OPTX Blank Checks
  • CLSD Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPTX Finance
  • CLSD Health Care
  • Exchange
  • OPTX Nasdaq
  • CLSD Nasdaq
  • Market Cap
  • OPTX 51.9M
  • CLSD 59.1M
  • IPO Year
  • OPTX N/A
  • CLSD 2016
  • Fundamental
  • Price
  • OPTX $1.36
  • CLSD $0.81
  • Analyst Decision
  • OPTX
  • CLSD Strong Buy
  • Analyst Count
  • OPTX 0
  • CLSD 5
  • Target Price
  • OPTX N/A
  • CLSD $4.80
  • AVG Volume (30 Days)
  • OPTX 73.0K
  • CLSD 419.9K
  • Earning Date
  • OPTX 08-13-2025
  • CLSD 08-11-2025
  • Dividend Yield
  • OPTX N/A
  • CLSD N/A
  • EPS Growth
  • OPTX N/A
  • CLSD N/A
  • EPS
  • OPTX 0.00
  • CLSD N/A
  • Revenue
  • OPTX $29,392,186.00
  • CLSD $3,764,000.00
  • Revenue This Year
  • OPTX N/A
  • CLSD $60.52
  • Revenue Next Year
  • OPTX N/A
  • CLSD $88.28
  • P/E Ratio
  • OPTX $846.97
  • CLSD N/A
  • Revenue Growth
  • OPTX 4.00
  • CLSD N/A
  • 52 Week Low
  • OPTX $0.85
  • CLSD $0.70
  • 52 Week High
  • OPTX $5.10
  • CLSD $1.65
  • Technical
  • Relative Strength Index (RSI)
  • OPTX 45.66
  • CLSD 47.98
  • Support Level
  • OPTX $1.27
  • CLSD $0.77
  • Resistance Level
  • OPTX $1.47
  • CLSD $0.82
  • Average True Range (ATR)
  • OPTX 0.11
  • CLSD 0.03
  • MACD
  • OPTX -0.00
  • CLSD 0.00
  • Stochastic Oscillator
  • OPTX 30.61
  • CLSD 37.50

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Share on Social Networks: